Pre-Clinical CNS Pipeline
Kv3.1/3.2 Program
Small molecule Kv3.1 / Kv3.2 potassium ion channels activators for improving cognitive dysfunction and negative symptoms in schizophrenia and other illnesses such as Autism Spectrum Disorder and Alzheimer’s Disease
Pan Nav Program
Small molecule pan Nav (1.7/1.8/1.9) inhibitors for the potential treatment of chronic pain and other potentially large unmet medical needs
For any partnering enquiries, please contact us here